pamidronate has been researched along with Ankylosing Spondylarthritis in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug." | 5.10 | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. ( Aaron, SL; Chiu, P; Davis, P; Fitzgerald, AA; Homik, J; Jhangri, GS; LeClercq, S; Maksymowych, WP; Russell, AS; Sholter, D; Skeith, KJ; Yan, A, 2002) |
| " Examination of the responsiveness of the individual components of the BASMI revealed significance for lumbar side flexion in the 60 mg dosing group (ES = 0." | 2.71 | Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. ( Conner-Spady, B; Jauregui, E; Maksymowych, WP; Russell, AS, 2004) |
| "Pamidronate (60 mg) was given intravenously on Days 1, 2, 14, 28, and 56, over 4 h in 500 ml of 5% dextrose." | 2.70 | Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. ( Aaron, S; Chiu, P; Jhangri, GS; Lambert, R; Leclercq, S; Maksymowych, WP; Russell, AS; Wong, B, 2001) |
| "Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery." | 2.42 | The treatment of ankylosing spondylitis. ( Davis, JC; Scalapino, KJ, 2003) |
| "A FREQUENT AFFECTION: Ankylosing spondylitis is a chronic inflammatory rheumatism usually affecting young adults and characterized by an inflammatory enthesiopathy progressing towards ossification and ankylosis." | 2.42 | [Ankylosing spondylitis]. ( El Maghraoui, A, 2004) |
| "Management of ankylosing spondylitis (AS) is challenged by the progressive nature of the disease." | 2.41 | Conventional treatments for ankylosing spondylitis. ( Brandt, J; Dijkmans, B; Dougados, M; Khan, M; Maksymowych, W; van der Linden, S, 2002) |
| " In addition, the long-term use (efficacy and tolerability) of these two agents deserves attention." | 2.41 | Therapeutic advances in ankylosing spondylitis. ( Toussirot, E; Wendling, D, 2001) |
| "A patient with ankylosing spondylitis, after demonstrating incomplete clinical response to adalimumab, received three monthly infusions of pamidronate along with continuing TNF-alpha blockade." | 1.36 | The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis. ( Boulman, N; Odeh, M; Rimar, D; Rosner, I; Rozenbaum, M; Slobodin, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 19 (82.61) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goh, L | 1 |
| Samanta, A | 1 |
| Slobodin, G | 1 |
| Rosner, I | 1 |
| Rimar, D | 1 |
| Boulman, N | 1 |
| Rozenbaum, M | 1 |
| Odeh, M | 1 |
| Santra, G | 1 |
| Sarkar, RN | 1 |
| Phaujdar, S | 1 |
| Banerjee, S | 1 |
| Siddhanta, S | 1 |
| De Langhe, E | 1 |
| Lories, R | 1 |
| Maenaut, K | 1 |
| De Vlam, K | 1 |
| Dougados, M | 2 |
| Dijkmans, B | 1 |
| Khan, M | 1 |
| Maksymowych, W | 2 |
| van der Linden, S | 1 |
| Brandt, J | 2 |
| Toussirot, E | 2 |
| Wendling, D | 2 |
| Singh, R | 1 |
| Menon, Y | 1 |
| Cuchacovich, R | 1 |
| Espinoza, LR | 1 |
| Scalapino, KJ | 1 |
| Davis, JC | 2 |
| Haibel, H | 1 |
| Rudwaleit, M | 1 |
| Soerensen, H | 1 |
| Sieper, J | 1 |
| Braun, J | 1 |
| Huang, F | 1 |
| Cairns, AP | 1 |
| Wright, SA | 1 |
| Taggart, AJ | 1 |
| Coward, SM | 1 |
| Wright, GD | 1 |
| Jauregui, E | 2 |
| Conner-Spady, B | 2 |
| Russell, AS | 5 |
| Maksymowych, WP | 5 |
| El Maghraoui, A | 1 |
| Akerkar, SM | 1 |
| Bichile, LS | 1 |
| Boulos, P | 1 |
| Macleod, SM | 1 |
| Hunsche, E | 1 |
| Grover, R | 1 |
| Shankar, S | 1 |
| Aneja, R | 1 |
| Marwaha, V | 1 |
| Gupta, R | 1 |
| Kumar, A | 1 |
| Mallon, C | 1 |
| Richardson, R | 1 |
| Chung, C | 1 |
| Zappala, L | 1 |
| Pile, K | 1 |
| Malaviya, AN | 1 |
| Kapoor, S | 1 |
| Garg, S | 1 |
| Ahmad, I | 1 |
| Raja, RR | 1 |
| Chogle, AR | 1 |
| Mishra, H | 1 |
| Chakravarty, A | 1 |
| Jhangri, GS | 3 |
| Leclercq, S | 3 |
| Skeith, K | 1 |
| Yan, A | 2 |
| Lambert, R | 1 |
| Chiu, P | 2 |
| Wong, B | 1 |
| Aaron, S | 1 |
| Fitzgerald, AA | 1 |
| Skeith, KJ | 1 |
| Aaron, SL | 1 |
| Homik, J | 1 |
| Davis, P | 1 |
| Sholter, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combined Treatment With TNF (Tumor Necrosis Factor) Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression[NCT02313727] | Phase 4 | 30 participants (Anticipated) | Interventional | 2014-12-31 | Not yet recruiting | ||
| Anti-Tumor Necrosis Factor (TNFR:Fc) in Ankylosing Spondylitis[NCT00000433] | Phase 2 | 42 participants | Interventional | 1999-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for pamidronate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclona | 2009 |
Conventional treatments for ankylosing spondylitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Azathioprine; Dipho | 2002 |
Recent progress in ankylosing spondylitis treatment.
Topics: Celecoxib; Controlled Clinical Trials as Topic; Diphosphonates; Drug Therapy; Humans; Methotrexate; | 2003 |
The treatment of ankylosing spondylitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antirheumatic Ag | 2003 |
New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
Topics: Anti-Inflammatory Agents; Diphosphonates; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Ag | 2003 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 2004 |
Pamidronate--a promising new candidate for the management of spondyloarthropathy.
Topics: Anti-Inflammatory Agents; Diphosphonates; Humans; Pamidronate; Spondylitis, Ankylosing | 2005 |
Pharmacological treatment of ankylosing spondylitis: a systematic review.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical | 2005 |
Therapeutic advances in ankylosing spondylitis.
Topics: Cyclooxygenase Inhibitors; Diphosphonates; Humans; Methotrexate; Pamidronate; Spondylitis, Ankylosin | 2001 |
7 trials available for pamidronate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.
Topics: Adult; Anti-Inflammatory Agents; Bone Remodeling; Collagen; Diphosphonates; Female; Humans; Male; Mi | 2005 |
Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
Topics: Adult; Aged; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administrat | 2004 |
Treatment of ankylosing spondylitis with pamidronate: an open label study.
Topics: Adult; Anti-Inflammatory Agents; Diphosphonates; Female; Humans; Male; Pamidronate; Severity of Illn | 2006 |
A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
Topics: Adolescent; Adult; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Drug Resi | 2007 |
An open study of pamidronate in the treatment of refractory ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Blood Sedimentation; Diphosphonates; Female; Humans; Male; Middle A | 1998 |
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Reactive; Blood Sedimentation; Bone Marrow; C-Reactive P | 2001 |
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diphosphonates | 2002 |
7 other studies available for pamidronate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dip | 2010 |
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sediment | 2010 |
The kaleidoscopic presentation of the spondyloarthritis concept in a female patient.
Topics: Acne Vulgaris; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis; Arthritis, Reacti | 2011 |
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et a
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diphosphonates; Double-Bli | 2003 |
Treatment of active ankylosing spondylitis with pamidronate.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up Studies; Hum | 2003 |
Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index.
Topics: Adult; Diphosphonates; Female; Hip Joint; Humans; Male; Observer Variation; Pamidronate; Radiography | 2006 |
A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; | 2007 |